[Immunosuppressive treatment of progressive chronic polyarthritis. Experiences with an antimitotic drug from the podophyllin series (Proresid)].
D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001799:Blood Sedimentation; D002097:C-Reactive Protein / Q000097:blood; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007275:Injections, Intravenous; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011033:Podophyllin / Q000008:administration & dosage / Q000009:adverse effects; D011035:Podophyllum / Q000008:administration & dosage* / Q000009:adverse effects; D012217:Rheumatoid Factor / Q000097:blood; D013582:Synovial Fluid / Q000032:analysis
D007166:Immunosuppressive Agents; D011033:Podophyllin; D002097:C-Reactive Protein; D012217:Rheumatoid Factor
Immunosuppressive Behandlung der progressiv-chronischen Polyarthritis. Erfahrungen mit einem Antimitotikum aus der Podophyllinreihe (Proresid)